Animal Research Benefits

To a scientist such as myself, who spent 40 years in pharmaceutical research and saw some 20 new drugs reach the market, it is shocking that a physician like Kenneth Stoller (The Scientist, Sept. 5, 1994, page 12) would have any doubts about the need for experimental animals in new drug research and development. Is he saying that he would administer a new drug to a human with no preclinical experience in animals? To himself, his family, his patients? Would he give a new drug to a human that sho

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

To a scientist such as myself, who spent 40 years in pharmaceutical research and saw some 20 new drugs reach the market, it is shocking that a physician like Kenneth Stoller (The Scientist, Sept. 5, 1994, page 12) would have any doubts about the need for experimental animals in new drug research and development. Is he saying that he would administer a new drug to a human with no preclinical experience in animals? To himself, his family, his patients? Would he give a new drug to a human that showed serious toxicity in a lower animal? If so, on what possible ethical basis? If not, how could he consider using any new compound in man without animal studies to rule out toxicities?

The Dr. Stollers of this world should have to answer these questions to justify their ridiculous and misguided depredation of the need for animals in drug research. Experimental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Charles Smith

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours